285 related articles for article (PubMed ID: 15679283)
1. Aprotinin and hemostasis monitoring concerns during cardiac surgery.
Swartz MF; Fink GW; Searles B
J Extra Corpor Technol; 2004 Dec; 36(4):375-83. PubMed ID: 15679283
[TBL] [Abstract][Full Text] [Related]
2. Aprotinin dosing: how much is enough?
Niimi KS
J Extra Corpor Technol; 2004 Dec; 36(4):384-90. PubMed ID: 15679284
[TBL] [Abstract][Full Text] [Related]
3. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study.
Dietrich W; Dilthey G; Spannagl M; Jochum M; Braun SL; Richter JA
Anesthesiology; 1995 Oct; 83(4):679-89; discussion 29A-30A. PubMed ID: 7574046
[TBL] [Abstract][Full Text] [Related]
4. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
5. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
[TBL] [Abstract][Full Text] [Related]
6. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
Augoustides JG
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
[No Abstract] [Full Text] [Related]
7. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
[TBL] [Abstract][Full Text] [Related]
8. Increased anticoagulation during cardiopulmonary bypass by aprotinin.
de Smet AA; Joen MC; van Oeveren W; Roozendaal KJ; Harder MP; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 Oct; 100(4):520-7. PubMed ID: 1699088
[TBL] [Abstract][Full Text] [Related]
9. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
10. Coagulation in cardiac surgery.
Royston D
Adv Card Surg; 1996; 8():19-45. PubMed ID: 9111648
[No Abstract] [Full Text] [Related]
11. Aprotinin in cardiac surgery.
Sodha NR; Boodhwani M; Bianchi C; Ramlawi B; Sellke FW
Expert Rev Cardiovasc Ther; 2006 Mar; 4(2):151-60. PubMed ID: 16509811
[TBL] [Abstract][Full Text] [Related]
12. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
Hill SE
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
[No Abstract] [Full Text] [Related]
13. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
Dietrich W
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
[TBL] [Abstract][Full Text] [Related]
14. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery.
Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN
Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013
[TBL] [Abstract][Full Text] [Related]
15. Use of aprotinin during cardiopulmonary bypass in a patient with protein C deficiency.
Sievert A; McCall M; Blackwell M; Bradley S
J Extra Corpor Technol; 2003 Mar; 35(1):39-43. PubMed ID: 12680495
[TBL] [Abstract][Full Text] [Related]
16. Celite and kaolin produce differing activated clotting times during cardiopulmonary bypass under aprotinin therapy.
Feindt P; Seyfert UT; Volkmer I; Straub U; Gams E
Thorac Cardiovasc Surg; 1994 Aug; 42(4):218-21. PubMed ID: 7529949
[TBL] [Abstract][Full Text] [Related]
17. Use of aprotinin in pediatric organ transplantation.
Spray TL
Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S71-3; discussion S74-6. PubMed ID: 9647143
[TBL] [Abstract][Full Text] [Related]
18. Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery.
Szabó G; Veres G; Radovits T; Haider H; Krieger N; Bährle S; Miesel-Gröschel C; Niklisch S; Karck M; van de Locht A
J Thorac Cardiovasc Surg; 2010 Jan; 139(1):181-8; discussion 188. PubMed ID: 20106364
[TBL] [Abstract][Full Text] [Related]
19. Alternative perioperative anticoagulation monitoring during cardiopulmonary bypass in aprotinin-treated patients.
Huyzen RJ; Harder MP; Huet RC; Boonstra PW; Brenken U; van Oeveren W
J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):153-6. PubMed ID: 7515704
[TBL] [Abstract][Full Text] [Related]
20. Review of efficacy parameters.
Pouard P
Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S40-3; discussion S43-4, S74-6. PubMed ID: 9647137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
